Counterfeit & Illegal Sales Domain Detection

The problem

Pharma and life sciences face domains that sell counterfeit products, run fake trials, or infringe IP. These threaten patient safety and brand integrity. You need detection and evidence to escalate to registrars and regulators.

• Domains selling counterfeit or unapproved products
• Fake clinical trial and recruitment sites
• Impersonation of providers and researchers
• Domains used in IP or patent infringement

How it works

1. 1

   Define your brands and risk scope

   You provide product names, trial names, and key marks. We set up monitoring for counterfeit, fake trial, and impersonation patterns.

2. 2

   Discover and classify

   We find domains that match your scope and classify by risk (e.g. counterfeit, fake trial, phishing). You get prioritized alerts.

3. 3

   Evidence and package

   We collect WHOIS, DNS, and content evidence. You get packages suitable for registrar takedown or regulatory reporting.

4. 4

   Escalate

   You submit to registrars or authorities. We do not submit on your behalf; we support you with evidence and workflow guidance.

Frequently asked questions

• Do you report to regulators for us?

  We do not report to regulators on your behalf. We provide evidence and documentation that you or your counsel can use when reporting to authorities.

• What evidence do registrars need for counterfeit domains?

  Registrars typically want clear proof of abuse (e.g. counterfeit sales, fake trial claims). We provide structured evidence that meets common abuse policy requirements.

• Can you monitor for fake clinical trials?

  Yes. We monitor for domains that suggest fake trials or recruitment. You get alerts and evidence so you can escalate to registrars or regulators as appropriate.

• How do you handle international domains?

  We identify the registrar and registry regardless of jurisdiction. Escalation may involve local authorities; we help with evidence and context for cross-border cases.

• Is this only for pharma?

  We built this with pharma and life sciences in mind, but the same detection and evidence approach can apply to other sectors with counterfeit or illegal sales risk (e.g. luxury, consumer health). Contact us to discuss.